Bar Harbor Wealth Management increased its stake in The Clorox Company (NYSE:CLX – Free Report) by 4.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,621 shares of the company’s stock after buying an additional 110 shares during the quarter. Bar Harbor Wealth Management’s holdings in Clorox were worth $358,000 as of its most recent filing with the SEC.
A number of other large investors have also modified their holdings of the stock. Vanguard Group Inc. grew its stake in Clorox by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock valued at $2,339,150,000 after purchasing an additional 48,632 shares in the last quarter. Point72 Asset Management L.P. bought a new position in Clorox during the 4th quarter worth approximately $144,844,000. Norges Bank acquired a new stake in Clorox in the 4th quarter valued at approximately $128,382,000. Parsifal Capital Management LP acquired a new stake in Clorox in the 4th quarter valued at approximately $128,245,000. Finally, Confluence Investment Management LLC acquired a new stake in Clorox in the 1st quarter valued at approximately $135,630,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on CLX shares. TD Cowen started coverage on Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target on the stock. Deutsche Bank Aktiengesellschaft lifted their price target on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Barclays lifted their price target on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research report on Monday, August 5th. Evercore ISI decreased their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a report on Wednesday, May 1st. Finally, Citigroup decreased their target price on Clorox from $150.00 to $145.00 and set a “neutral” rating for the company in a research report on Wednesday, July 10th. Six equities research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $141.94.
Clorox Trading Down 0.0 %
NYSE:CLX traded down $0.07 during trading hours on Friday, hitting $145.86. 382,630 shares of the stock were exchanged, compared to its average volume of 1,257,116. The company’s 50 day moving average is $136.22 and its two-hundred day moving average is $142.43. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $158.89. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The company has a market capitalization of $18.11 billion, a P/E ratio of 75.61, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39.
Clorox Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th will be issued a dividend of $1.22 per share. This is an increase from Clorox’s previous quarterly dividend of $1.20. The ex-dividend date of this dividend is Tuesday, August 13th. This represents a $4.88 annualized dividend and a yield of 3.35%. Clorox’s dividend payout ratio is currently 252.85%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- 10 Best Airline Stocks to Buy
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
- The Significance of Brokerage Rankings in Stock Selection
- Warren Buffett’s Recent Stock Moves: Top Buys and Sells to Watch
- What is the Shanghai Stock Exchange Composite Index?
- Sea Limited’s E-Commerce and Fintech Strength Fuel Stock Surge
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.